Teduglutide is a dipeptidyl peptidase IV resistant glucagon-like peptide 2 (GLP-2) analogue. Teduglutide is associated with trophic effects on gut mucosa. Teduglutide can be used for the research of short bowel syndrome (SBS) and Crohns disease (CD).
性状
Solid
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Sealed storage, away from moisture and light, under nitrogenPowder -80°C 2 years;-20°C 1 ye
ClinicalTrial
SequenceShortening
HGDGSFSDEMNTILDNLAARDFINWLIQTKITD
参考文献
[1]. Jeppesen PB, et al. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut. 2005 Sep;54(9):1224-31.[2]. Buchman AL, et al; Teduglutide Study Group. Teduglutide, a novel mucosally active analog of glucagon-like peptide-2 (GLP-2) for the treatment of moderate to severe Crohns disease. Inflamm Bowel Dis. 2010 Jun;16(6):962-73.
溶解度数据
In Vitro: DMSO : 50 mg/mL (13.33 mM; Need ultrasonic)配制储备液